Evidence map›Paper›PMID 25672466›Full record

ArticleBiochemia medica2015

Ten years of preanalytical monitoring and control: Synthetic Balanced Score Card Indicator.

Maria Salinas, Maite López-Garrigós, Emilio Flores, Ana Santo-Quiles, Mercedes Gutierrez, Javier Lugo, Rosa Lillo, Carlos Leiva-Salinas

Abstract read
In one paragraph

Article in Biochemia medica, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Errors in the Extra-Analytical Phases of Clinical Chemistry Laboratory Testing.Indian journal of clinical biochemistry : IJCB · 2018
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Maria SalinasClinical Laboratory, Hospital Universitario de San Juan, San Juan de Alicante, Spain ; Department of Biochemistry and Molecular Pathology, Universidad Miguel Hernandez, Elche, Spain.
Maite López-GarrigósClinical Laboratory, Hospital Universitario de San Juan, San Juan de Alicante, Spain ; Department of Biochemistry and Molecular Pathology, Universidad Miguel Hernandez, Elche, Spain.
Emilio FloresClinical Laboratory, Hospital Universitario de San Juan, San Juan de Alicante, Spain ; Department of Clinic Medicine, Universidad Miguel Hernandez, Elche, Spain.
Ana Santo-QuilesClinical Laboratory, Hospital Universitario de San Juan, San Juan de Alicante, Spain.
Mercedes GutierrezClinical Laboratory, Hospital Universitario de San Juan, San Juan de Alicante, Spain.
Javier LugoClinical Laboratory, Hospital Universitario de San Juan, San Juan de Alicante, Spain.
Rosa LilloClinical Laboratory, Hospital Universitario de San Juan, San Juan de Alicante, Spain.
Carlos Leiva-SalinasDepartment of Radiology, University of Virginia, Charlottesville, VA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPreanalytical control and monitoring continue to be an important issue for clinical laboratory professionals. The aim of the study was to evaluate a monitoring system of preanalytical errors regarding not suitable samples for analysis, based on different indicators; to compare such indicators in different phlebotomy centres; and finally to evaluate a single synthetic preanalytical indicator that may be included in the balanced scorecard management system (BSC). MATERIALS AND

methodsWe collected individual and global preanalytical errors in haematology, coagulation, chemistry, and urine samples analysis. We also analyzed a synthetic indicator that represents the sum of all types of preanalytical errors, expressed in a sigma level. We studied the evolution of those indicators over time and compared indicator results by way of the comparison of proportions and Chi-square.

resultsThere was a decrease in the number of errors along the years (P<0.001). This pattern was confirmed in primary care patients, inpatients and outpatients. In blood samples, fewer errors occurred in outpatients, followed by inpatients.

conclusionWe present a practical and effective methodology to monitor unsuitable sample preanalytical errors. The synthetic indicator results summarize overall preanalytical sample errors, and can be used as part of BSC management system.

Indexed as

Clinical Laboratory TechniquesCross-Sectional StudiesDiagnostic ErrorsFemaleForms and Records ControlHumansMaleMedical RecordsRetrospective Studiesbalanced scorecarderrors in laboratory medicinepatient safetyPreanalytical phase

Identifiers

PMID25672466
PMCPMC4401317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.